ERCP Topics

Endoscopy

Volumn 33, Issue 11, 2001, Pages 930-939

  Connor, P ^a   Hawes, R H ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NIFEDIPINE; OCTREOTIDE;

BILIARY TRACT DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC IMAGING; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; IMAGE QUALITY; LITHOTRIPSY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALIGNANT TRANSFORMATION; MINIMALLY INVASIVE SURGERY; ODDI SPHINCTER; PANCREATITIS; PRIORITY JOURNAL; PROPHYLAXIS; STENT; SURGICAL APPROACH; SURGICAL TECHNIQUE; VATER PAPILLA STENOSIS; VATER PAPILLA TUMOR;

BILIARY TRACT; BILIARY TRACT DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; PANCREAS; PANCREATIC DISEASES;

EID: 0034758626     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17924     Document Type: Conference Paper

References (71)

1. MRCP versus ERCP in the evaluation of patients with suspected biliopancreatic disease: Can ERCPs be saved
2. Which information can MRCP provide prior to interventional ERCP? A prospective comparative study
3. A comparative study of magnetic resonance cholangiography and direct cholangiography
4. Choledocholithiasis: Evaluation of MR cholangiography for diagnosis
5. Diagnostic accuracy of magnetic resonance cholangiopancreatography and ultrasound compared with direct cholangiography in the detection of choledocholithiasis
6. Virtual pancreatoscopy using transabdominal three-dimensional ultrasound
7. Prevention of acute post-ERCP pancreatitis with heparin? Final results of a prospective study in risk factors for AP
8. Octreotide acetate pretreatment in the prevention of post ERCP abdominal pain
9. Antibiotic prophylaxis reduces post-ERCP pancreatitis
10. Transdermal glyceryl trinitrate in the prevention of post-ERCP pancreatitis
11. Pharmacologic treatment can prevent pancreatic injury after ERCP: A meta-analysis
12. 24-hour prophylaxis with octreotide in high-risk patients for post-ERCP pancreatitis: Results of a multicenter, randomized trial
13. Nifedipine for post-ERCP pancreatitis prophylaxis: Results of a prospective, double-blind randomized study
14. Silent myocardial ischaemia during endoscopic retrograde cholangiopancreatography (ERCP)
15. Vagal withdrawal during endoscopic retrograde cholangiopancreatography
16. Metoprolol prevents myocardial ischemia during endoscopic retrograde cholangiopancreatography
17. Double blind randomised controlled trial of effect of metoprolol on myocardial ischaemia during endoscopic cholangiopancreatography
18. Hypoxaemia and myocardial ischaemia during and after endoscopic cholangiopancreatography: Call for further studies
19. Biliary complications of orthotopic liver transplantation
20. Endoscopic management of biliary complications after orthotopic liver transplantation
21. Biliary tract strictures after orthotopic liver transplantation: Diagnosis and management
22. Endoscopic management of postoperative biliary complications in orthotopic liver transplantation
23. Management of extrahepatic biliary disease after orthotopic liver transplantation: Review of the literature and results of a multicenter survey
24. Endoscopic therapy of anastomotic bile duct strictures occurring after liver transplantation
25. The use of multiple stents (MS) in the management of liver transplantation-related biliary stricture (LTBS): Long-term follow-up
26. Papillary dilation vs. sphincterotomy in endoscopic removal of bile duct stones: A randomized trial with manometric function
27. Endoscopic papillary dilation (EPD) for the treatment of common bile duct stones and papillary stenosis
28. Endoscopic papillary dilatation: An alternative to papillotomy?
29. Endoscopic balloon dilatation vs. sphincterotomy (EDES) for bile duct stone removal
30. Endoscopic sphincterotomy (EST) and endoscopic papillary balloon dilatation (EPBD) for bile duct stones: Preliminary report on a randomized controlled multicenter trial
31. Shortened duration of balloon dilatation may reduce the incidence of pancreatitis and the elevation of serum amylase after endoscopic papillary balloon dilatation for extracting bile duct stones
32. Transnasal extraction (TNE) of residual common bile duct (CBD) stones by the Seldinger technique
33. Laser lithotripsy of difficult bile duct stones: Results in 60 patients using a rhodamine 6G dye laser with optical stone tissue detection system
34. In vitro study concerning the efficiency of the frequency-doubled double-pulse neodymium:YAG laser (FREDDY) for lithotripsy of calculi in the urinary tract
35. First clinical data on laser lithotripsy of common bile duct stones with a new frequency-doubled double-pulse Nd:YAG-laser (FREDDY) in 19 patients
36. Endoscopic management of biliary leaks after T-tube removal in liver transplant recipients: Nasobiliary drainage versus biliary stenting
37. The role of ERCP in diagnosis and management of accessory bile duct leaks after cholecystectomy
38. Endoscopic nasobiliary drainage for treating bile leak after laparoscopic cholecystectomy
39. Endoscopic intervention for biliary leaks after laparoscopic cholecystectomy: A multicenter review
40. Cystic duct leak closure using poly-n-acetyl glucosamine (p-glc-nac) results in a swine model
41. Sphincter of Oddi injection with botulinum toxin is as effective as endobiliary stenting in resolving cystic duct leaks in a canine model
42. Endoscopic placement of expandable metal stents for biliary strictures: A preliminary report on experience with 33 patients
43. Clinical experience with covered Wallstents for biliary malignancies: 23-month follow-up
44. Metallic stents in malignant biliary obstruction: Results of a multicenter European study of 240 patients
45. Biliary stent occlusion: A problem solved with self-expanding metal stents? European Wallstent Study Group
46. Multicenter randomized comparative trial of the new spiral Z-stent compared to Wallstent: Final results of the ZOOM study
47. Multi-center clinical experience with percutaneous transhepatic deployment (PTD) and endoscopic retrograde deployment (ERD) of an EPTFE-lined nitinol biliary self-expanding metal stent (SEMS)
48. A prospective randomized study of "covered" vs. "uncovered" Diamond stent for malignant biliary obstruction
49. Clinical evaluation of covered metallic stents vs. bare stents for malignant biliary strictures: Results of a multicenter study in Japan
50. Long-term follow up of covered metal stents versus uncovered metal stents for malignant extrahepatic bile duct obstruction
51. Distribution and pharmacokinetics of Photofrin in human bile duct cancer
52. Therapy of pancreatic and bile duct tumors: Value of radiotherapy and photodynamic therapy
53. The change in laser usage in gastroenterology: Status in 1997
54. Conversion from percutaneous to transpapillary drainage in non-resectable bile duct cancer is possible after photodynamic therapy (PDT)
55. Photodynamic therapy of non-resectable cholangiocarcinoma: A randomized prospective study-first results
56. Diagnosis of sphincter of Oddi dysfunction: Comparison of sphincter of Oddi manometry, fatty meal sonography and hepatobiliary scintigraphy
57. Treatment of sphincter of Oddi dysfunction by endoscopic sphincterotomy: Clinical response predicted by hepatobiliary scintigraphy and fatty meal sonography
58. Does secretin-stimulated ultrasound (SSU) predict results of sphincter of Oddi manometry (SOM), basal sphincter pressure (BSP) in patients suspected of having sphincter of Oddi dysfunction (SOD)?
59. Sphincter of Oddi manometry (SOM): Effects of droperidol in the biliary and pancreatic sphincter
60. Prospective evaluation of droperidol on sphincter of Oddi manometry
61. An endoscopic animal model of sphincter of Oddi dysfunction
62. Long-term follow-up of patients undergoing sphincter of Oddi manometry (SOM) and sphincterotomy (S): Evidence for a chronic pain syndrome
63. Effectiveness in endotherapy in the treatment of chronic pancreatitis associated with SOD
64. Long-term outcome of patients after endoscopic treatment of duodenal benign ampullomas
65. Pancreatic endotherapy of pancreas divisum (PDV): Response based on clinical presentation and results of secretin-stimulated endoscopic ultrasound (S-EUS)
66. Pancreatic ductal alterations following small diameter, long length, unflanged pancreatic duct (PD) stent placement
67. The management of pancreatic duct (PD) stenting for obstructive-type pain of pancreatic cancer
68. Endoscopic therapy of chronic pancreatitis (CP): Long-term follow-up
69. ERCP and ESWL for refractory pancreatic duct stones: Do we really improve pain, preclude the need for surgery?
70. Treatment of chronic pancreatitis using "definitive" stenting of the main pancreatic duct
71. New endoscopic method for debridement of infected peripancreatic necrosis